South Korea eases quasi-drug licensing rules for GMP-compliant overseas facilities

Verifying
  • The Ministry of Food and Drug Safety proposed revised quasi-drug licensing and review regulations.
  • September 23 is the deadline for submitting opinions on the notified revision.
  • Eligible GMP-compliant overseas facilities may receive manufacturing-certificate exemptions for specified preparations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.